The science of what the drug does to the body and what the body does to the drug.
Aristotle’s successor at the Lyceum and the founder of botany. His De Historia Plantarum (nine books) and De Causis Plantarum (six books) are the first systematic works on plant classification, physiology, and pharmacology. He documented the knowledge of the rhizotomoi — the root-cutters, the professional herbalists of the ancient world — and classified plants by their medicinal properties, their juices, their habitats, and their effects on the body. Every subsequent pharmacopoeia descends from his taxonomy.
Can help you study: Ancient botany, De Historia Plantarum, De Causis Plantarum, medicinal plants, the rhizotomoi, plant classification, Aristotelian natural history, and the argument that you cannot prescribe a drug until you have classified the plant it comes from.
Greek physician from Anazarbus in Cilicia who wrote De Materia Medica — the most influential pharmacopoeia in history, standard for fifteen centuries. He described approximately 600 plants, 35 animal products, and 90 minerals, organised not alphabetically but by therapeutic effect. He walked the provinces of the Roman Empire testing remedies himself. His method: field observation outranks book learning. The Vienna manuscript (6th century) preserves his plant illustrations. He also appears in Medicine.
Can help you study: De Materia Medica, ancient pharmacology, medicinal plants, the organisation of remedies by effect rather than name, field observation, and the argument that the pharmacopoeia must be built from the ground up.
Physician to Roman gladiators and emperors whose pharmacological system — the four qualities (hot, cold, wet, dry) graded in four degrees — governed drug compounding for fourteen centuries. His De Simplicium Medicamentorum and De Compositione Medicamentorum systematised how drugs are classified, combined, and prescribed. He argued that the physician must also be a philosopher — that compounding a drug requires understanding the theory behind it. He also appears in Medicine.
Can help you study: Galenic pharmacology, the four qualities and four degrees, compound drugs, De Simplicium Medicamentorum, the physician-philosopher, and the argument that rational drug therapy requires a theoretical framework.
Persian polymath whose Canon of Medicine (al-Qanun fi al-Tibb) was the standard medical and pharmacological textbook in both the Islamic world and Europe for six centuries. He formulated seven rules for testing drugs — the first systematic protocol for clinical drug evaluation — including the requirements that the drug be tested on more than one disease, that its effects be observed in both simple and compound forms, and that the experiment be repeated. He also appears in Medicine.
Can help you study: The Canon of Medicine, the seven rules of drug testing, tajribah (empirical testing), qiyas (analogical reasoning), Islamic pharmacology, and the argument that medicine requires both philosophy and experiment.
Andalusian-born botanist and pharmacologist who walked from Málaga across North Africa to Damascus, cataloguing every medicinal plant he encountered. His Kitab al-Jami li-Mufradat al-Adwiya wa-l-Aghdhiya describes over 1,400 medicinal substances — 300 of them new — and systematically corrects Dioscorides where field observation contradicts the received text. It is the largest and most comprehensive pharmacopoeia of the medieval world. His name means “son of the veterinarian.”
Can help you study: The Kitab al-Jami, Islamic pharmacology, field botany, correcting received authorities from observation, Andalusian science, and the argument that the pharmacopoeia must be walked, not copied.
Swiss-German physician, alchemist, and revolutionary who burned Avicenna’s Canon in the public square at Basel in 1527 and declared that medicine must be rebuilt from observation and chemistry, not from ancient authority. He formulated the founding axiom of pharmacology: sola dosis facit venenum — the dose makes the poison. Everything is toxic; only the dose distinguishes a poison from a remedy. He also proposed the tria prima (salt, sulphur, mercury) as the basis of chemical medicine, founding iatrochemistry. He was expelled from Basel within a year.
Can help you study: Sola dosis facit venenum, iatrochemistry, the tria prima, the Basel bonfire, the rupture with Galenic medicine, and the argument that the dose — not the substance — is what matters.
German pharmacologist and toxicologist who wrote Phantastica (1924) — the first systematic classification of psychoactive substances, dividing them into five groups: Euphorica, Phantastica, Inebriantia, Hypnotica, and Excitantia. He was the first European scientist to study peyote pharmacologically (the cactus Anhalonium lewinii was named in his honour). He combined laboratory pharmacology with global ethnobotanical fieldwork decades before Schultes. He bridges pharmacology and psychedelics.
Can help you study: Phantastica, the five-group classification of psychoactive substances, peyote pharmacology, ethnobotanical pharmacology, toxicology, and the argument that the pharmacologist must study the intoxicants of all peoples, not just the medicines of his own.
Cambridge physiologist who mapped the autonomic nervous system, named its three divisions (autonomic, sympathetic, parasympathetic), and proposed the concept of “receptive substances” on cell surfaces — the first articulation of the receptor concept. His nicotine-curare experiments on denervated muscle demonstrated that drugs act on the cell itself, not on the nerve. He edited the Journal of Physiology for thirty-one years.
Can help you study: The receptor concept, the autonomic nervous system, nicotine and curare, chemical transmission, the physiological route to pharmacology, and the argument that the drug acts on the cell, not the nerve.
German physician who formulated the principle corpora non agunt nisi fixata — bodies do not act unless bound — and spent his career looking for the “magic bullet”: a chemical that kills the pathogen and spares the host. His side-chain theory of immunity proposed that cells carry specific receptors that bind to toxins and drugs. Compound 606 (Salvarsan) was the first effective treatment for syphilis and the founding achievement of chemotherapy. He also predicted drug resistance. Nobel Prize 1908. He also appears in Medicine.
Can help you study: The magic bullet, the side-chain theory, Salvarsan, the receptor as the foundation of pharmacology, drug resistance, histological staining, and the argument that selectivity is the central problem of drug design.
German-born pharmacologist who proved that nerves transmit signals by releasing chemical substances, not by electrical impulse alone. On Easter Saturday 1921, he dreamed the experiment, woke, scribbled notes, could not read them in the morning, dreamed it again the next night, went straight to the laboratory, and performed the famous two-frog-heart experiment: stimulating the vagus nerve of one heart released a substance (he called it Vagusstoff — later identified as acetylcholine) that slowed the second heart. Nobel Prize 1936 with Dale. The Nazis forced him to hand over the prize money after the Anschluss.
Can help you study: Chemical neurotransmission, the Vagusstoff experiment, acetylcholine, the autonomic nervous system, the dream as method, and the argument that the most important experiments are sometimes the simplest.
British pharmacologist who identified acetylcholine as a neurotransmitter in the peripheral nervous system, isolated histamine, and named the two branches of autonomic chemical transmission “cholinergic” and “adrenergic” — terminology that has governed pharmacology ever since. He extracted acetylcholine from ergot, demonstrated its muscarinic and nicotinic actions, and proved that the same transmitter operates at multiple sites with different effects depending on the receptor. Nobel Prize 1936 with Loewi.
Can help you study: Acetylcholine, cholinergic and adrenergic transmission, histamine, muscarinic and nicotinic receptors, the Dale-Loewi collaboration, and the argument that the transmitter is universal but the receptor determines the response.
Scottish physician and microbiologist who noticed in 1928 that a mould contaminating a staphylococcal culture plate had killed the surrounding bacteria. Most people would have thrown the plate away. Fleming did not. He identified the mould as Penicillium notatum, named the antibacterial substance penicillin, and published. He could not purify it in sufficient quantity for clinical use — that took Florey and Chain a decade later. He also warned, from the beginning, that bacteria would develop resistance if penicillin were used carelessly. Nobel Prize 1945.
Can help you study: Penicillin, the contaminated plate, serendipity as prepared recognition, antibiotic resistance, the gap between discovery and development, and the argument that observation is worthless without the prepared mind.
Ukrainian-born American microbiologist who systematised antibiotic discovery by screening soil micro-organisms for antibacterial activity — a method that was industrial in scale and ecological in conception. He coined the word “antibiotic.” His laboratory discovered streptomycin (1943), the first effective treatment for tuberculosis. The credit question — his student Albert Schatz did the bench work and sued for co-credit — is one of the most instructive cases of authorship ethics in science. Nobel Prize 1952.
Can help you study: Streptomycin, soil microbiology, systematic drug screening, the term “antibiotic,” the Schatz credit dispute, and the argument that drug discovery can be industrialised without losing its ecological intelligence.
German pathologist who tested a red azo dye (Prontosil) on his own gravely ill daughter Hildegard in 1935 — and it worked. Prontosil was the first synthetic antibacterial drug, the founding sulfonamide. It worked not because the dye killed bacteria directly but because the body metabolised it into the active compound sulfanilamide. Nobel Prize 1939 — but the Nazi government forced him to decline it. He accepted it after the war.
Can help you study: Prontosil, sulfonamides, the industrial screen, prodrug metabolism, the first synthetic antibacterial, and the argument that sometimes the drug you test is not the drug that works.
American pharmacologist who built the rational drug design programme at Burroughs Wellcome — the laboratory that produced 6-mercaptopurine (leukaemia), azathioprine (organ transplant rejection), trimethoprim (bacterial infections), acyclovir (herpes), and AZT (HIV). His method: find the biochemical difference between the diseased cell and the healthy cell, then design a drug that exploits the difference. He hired Gertrude Elion as his research partner. Nobel Prize 1988 with Elion and Black.
Can help you study: Rational drug design, antimetabolites, nucleic acid metabolism as drug target, programme architecture, the Hitchings-Elion partnership, and the argument that the laboratory must outlast the director.
Liverpool-born American pharmacologist who founded the science of drug metabolism — the systematic study of what the body does to the drug. Before Brodie, pharmacologists studied what drugs do to the body; he asked the reverse question and built the methods to answer it. At the NIH he trained an extraordinary dynasty of scientists (Axelrod, Burns, Udenfriend, Costa, Gillette) and his reserpine experiments with Carlsson led to the monoamine hypothesis of depression. He also showed that serotonin exists in the brain.
Can help you study: Drug metabolism, biochemical pharmacology, reserpine, serotonin, the monoamine hypothesis, laboratory mentorship, and the argument that methodology drives science — build the assay and the discoveries follow.
American pharmacologist who proposed in 1948 that there are two types of adrenergic receptor — alpha and beta — distinguished not by the organ they sit on but by the rank order of potency of a series of agonists. The paper was rejected by every major journal and eventually published in the American Journal of Physiology. It took a decade for the field to accept it. James Black then used the beta receptor concept to develop propranolol (the first beta-blocker), winning the Nobel Prize. Ahlquist did not.
Can help you study: Alpha and beta adrenoceptors, receptor subtype classification, rank order of potency, the rejected paper, the road to beta-blockers, and the argument that the right idea published in the wrong decade is still the right idea.
American biochemist who never completed a PhD (no graduate programme would admit a woman full-time in the 1940s) and went on to design drugs that treat leukaemia, herpes, gout, malaria, and organ transplant rejection. Working with George Hitchings at Burroughs Wellcome, she developed 6-mercaptopurine, azathioprine, allopurinol, trimethoprim, and acyclovir — each designed rationally from biochemical first principles, not discovered by chance. Nobel Prize 1988.
Can help you study: Rational drug design, acyclovir, 6-mercaptopurine, azathioprine, selective toxicity, antimetabolites, the Hitchings-Elion partnership, and the argument that understanding the biochemistry comes before designing the drug.
Swedish pharmacologist who proved that dopamine is a neurotransmitter in its own right — not merely a precursor to norepinephrine. His reserpine-L-DOPA experiment (1957) showed that reserpine depletes dopamine, causing Parkinsonian symptoms, and L-DOPA restores it. This led directly to the L-DOPA treatment of Parkinson’s disease. He also laid the groundwork for understanding antipsychotic drug action and contributed to the development of SSRIs. Nobel Prize 2000.
Can help you study: Dopamine, the reserpine-L-DOPA proof, Parkinson’s disease, antipsychotics, SSRIs, CNS pharmacology, and the argument that the brain’s chemistry determines its function.
Scottish pharmacologist who took Ahlquist’s rejected receptor classification and built two of the most important drugs of the twentieth century from it: propranolol (the first beta-blocker, for angina and hypertension) and cimetidine (the first H2-receptor antagonist, for peptic ulcer). He called his method “syntopic antagonism” — designing a molecule that fits the receptor but blocks the natural transmitter. Nobel Prize 1988 with Hitchings and Elion.
Can help you study: Beta-blockers, H2 antagonists, propranolol, cimetidine, syntopic antagonism, receptor-based drug design, and the argument that the best drug design starts with the receptor, not the disease.
Japanese biochemist who discovered the first statin — compactin (mevastatin) — by screening soil fungi for HMG-CoA reductase inhibitors in the early 1970s. His hypothesis: fungi competing with bacteria would produce metabolites that block cholesterol synthesis. He was right. His employer, Sankyo, abandoned the drug after animal studies. Merck independently developed lovastatin. Statins became the most prescribed class of drugs in history. Endo did not share in the commercial reward.
Can help you study: Statins, HMG-CoA reductase, compactin, the ecological source hypothesis, compensatory upregulation, discovery without development, and the argument that the discoverer and the developer are rarely the same person.
American neuroscientist who identified the opiate receptor in 1973 at the age of twenty-six, as a graduate student in Solomon Snyder’s laboratory at Johns Hopkins. Her radioligand binding assay demonstrated that opiates act by binding to specific receptors in the brain — which implied that the brain must produce its own endogenous opioids (later identified as endorphins and enkephalins). The discovery opened the field of neuropeptide pharmacology. The credit question — Snyder was nominated for the Lasker Prize; Pert was not — became a landmark case in scientific authorship ethics.
Can help you study: The opioid receptor, radioligand binding, endorphins, neuropeptide pharmacology, the Snyder-Pert credit dispute, and the argument that the person who does the experiment deserves the recognition.